Thursday, December 4, 2025
8:00 AM PT / 11:00 AM ET
As the biopharma industry’s reliance on CMOs continues to expand across biologics, sterile injectables, and emerging modalities, both sponsors and contract manufacturers face increasing expectations for oversight, alignment, and data-driven quality management.
Join a rare opportunity to hear directly from senior CMO executives shaping the future of quality and compliance across the global biopharma landscape, moderated by Michael de la Torre, CEO of Redica Systems. Together, they’ll share sponsor and CMO perspectives on the evolving state of quality, compliance, and collaboration in today’s complex outsourcing environment.
A few questions the panel will explore:
- How have expectations of CMOs changed in recent years?
- What does “good oversight” look like from each side of the partnership?
- How can data transparency strengthen sponsor–CMO relationships?
- What innovations or mindset shifts will shape the next generation of CMO quality?
Register today to join the discussion and share your questions with the panelists.
Robin Kumoluyi
VP, Quality at Thermo Fisher Scientific
Dawn Carlson
VP, Global Compliance and Regulatory Affairs at Simtra
Helen Bickley
VP, Quality Operations at Fujifilm Diosynth Biotechnologies
Dr. Joerg Schnitzler
Corp. VP, Head of Global Quality BioPharma at Boehringer Ingelheim
If you have trouble registering, please contact events@redica.com.